Emerging Nanozymes in Neurological Disorder Therapeutics: Bridging Oxidoreductase Mimicry and Antioxidant Chemistry
Advanced Functional Materials · 2024-09 · 34 (39)
DOI: 10.1002/adfm.202405190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 03.07.2024. Verfasst von Guohui Jiang und 8 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 188 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
The prevalence of neurological dieases, including neurodegenerative, neurotraumatic disorders, and neuroinflammatory conditions, has been rising due to global population and aging demographics. A key factor in the pathogenesis of these disorders is the hyperaccumulation of reactive oxygen and nitrogen species (RONS). Nanozymes have emerged as promising candidates for neurotherapeutic applications owing to their exceptional catalytic activity and stability. Of particular note is their ability to cross the blood‐brain barrier and counteract the production of reactive oxygen species via their enzyme‐mimicking characteristics. In this review, the latest advancements and theoretical knowledge in this research domain are summarized. Using the inherent functionalities of the Web of Science and bibliometric methodologies, annual publication trends are identified and extensively explored the most researched topics and neurological disorders in this field. The antioxidant reduction chemistry of the nanozymes is discussed, highlighting their ability to mimic natural oxidoreductase activity and inhibit RONS production at the source. Moreover, this review delves into the current limitations and future prospects of these mechanisms in addressing neurological disorders. The significant benefits and recent developments in the use of RONS‐regulating nanozymes for the treatment of neurological diseases are emphasized, offering insights into their therapeutic applications and broader implications for neurology.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Jiang, G., Xu, Q., Xie, J., You, Y., Cai, L., Zhao, L., Tang, X., Yang, H., & Yong, Y. (2024). Emerging Nanozymes in Neurological Disorder Therapeutics: Bridging Oxidoreductase Mimicry and Antioxidant Chemistry. Advanced Functional Materials, 34(39). https://doi.org/10.1002/adfm.202405190
Vancouver
Jiang G, Xu Q, Xie J, You Y, Cai L, Zhao L, et al. Emerging Nanozymes in Neurological Disorder Therapeutics: Bridging Oxidoreductase Mimicry and Antioxidant Chemistry. Advanced Functional Materials. 2024;34(39). doi:10.1002/adfm.202405190
BibTeX
@article{Jiang2024,
author = {Jiang, Guohui and Xu, Qiqi and Xie, Jiani and You, Yong and Cai, Lulu and Zhao, Long and Tang, Xiaoping and Yang, Hanfeng and Yong, Yuan},
title = {Emerging Nanozymes in Neurological Disorder Therapeutics: Bridging Oxidoreductase Mimicry and Antioxidant Chemistry},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {39},
doi = {10.1002/adfm.202405190}
}
EUVIMED